CDKN2A and neoplasm: In analogy to idea that cells involved in entosis have a ‘winner’ or ‘loser’ status based on cell deformability [15], entosis could therefore cause selection for those ‘winner’ tumour cells that have acquired mutations in Myc, KRAS, CDKN2A or Tp53 and lead to heterogeneity that is seen within many tumours.